Up-regulation of GGH has been described to occur in several neoplasias, including breast and colon cancers, pulmonary neuroendocrine tumors, and hematological cancers [8,9,10,11], and has been linked to adverse tumor features and poor clinical outcome in some of them [8,11]. Here, GGH is linked to neoplasm.